Palisade Bio Inc. (NASDAQ: PALI) Stock Information | RedChip

Palisade Bio Inc. (NASDAQ: PALI) Listen to this Section


$3.94
+0.2250 ( +6.07% ) 19.2K

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Market Data


Open


$3.94

Previous close


$3.71

Volume


19.2K

Market cap


$3.69M

Day range


$3.53 - $3.95

52 week range


$3.30 - $28.95

Insider Ownership Transactions

Total Amount Purchased: -10,128.00 | $ -39,853.68

Date Type Amount Purchased Purchaser
2024-07-15 Sale -2100.00 Williams Donald Allen
2024-07-15 Sale -2100.00 Fischbein Margery B.
2024-07-15 Sale -2100.00 Wei Binxian
2024-06-12 Sale -465.00 Wei Binxian
2024-06-12 Sale -340.00 Williams Donald Allen
2024-05-30 Sale -2735.00 Jones Mitchell Lawrence
2024-05-30 Sale -1622.00 Finley John David
2024-05-29 Buy 1000.00 Williams Donald Allen
2024-05-28 Buy 1000.00 Finley John David
2024-05-22 Sale -666.00 Finley John David

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 54 Aug 12, 2024
4 Insider transactions 1 Jul 15, 2024
4 Insider transactions 1 Jul 15, 2024
4 Insider transactions 1 Jul 15, 2024
8-k 8K-related 13 Jul 08, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 Jun 12, 2024
4 Insider transactions 1 May 30, 2024
4 Insider transactions 1 May 30, 2024
4 Insider transactions 1 May 29, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.